User profiles for D. Vega-Morales

David Vega Morales

Instituto Mexicano del Seguro Social
Verified email at uanl.edu.mx
Cited by 673

Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry

SA Bergstra, JC Branco, D Vega-Morales… - Annals of the …, 2018 - ard.bmj.com
Objective To establish in a global setting the relationships between countries’
socioeconomic status (SES), measured biological disease modifying antirheumatic drug (bDMARD)-…

Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage

…, LM Suárez-Larios, D Vega-Morales… - The Journal of …, 2014 - jrheum.org
Objective. To evaluate factors associated with mortality and infections in patients with
systemic lupus erythematosus (SLE) and diffuse alveolar hemorrhage (DAH). Methods. A …

Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis

…, LAM Martínez, D Vega-Morales… - … Clínica (English Edition), 2014 - Elsevier
Background The pharmacologic management of rheumatoid arthritis has progressed
substantially over the past years. It is therefore desirable that existing information be periodically …

Efficacy and safety of weekly vitamin D3 in patients with fibromyalgia: 12-week, double-blind, randomized, controlled placebo trial

LI Lozano-Plata, D Vega-Morales… - Clinical …, 2021 - Springer
… This study showed that patients with FM had severe vitamin D abnormal values in Vitamin
D levels up to 75%. Vitamin D deficiency even occurs in countries with intense sunlight. The …

Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America

…, JC Casasola, D Vega Morales… - Clinical …, 2020 - Springer
Introduction Physician-patient misalignment may exist in real-life clinical practice. We aimed
to assess physician and patient treatment satisfaction levels and associated degree of …

Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practice

…, N Govind, EA Murphy, D Vega-Morales… - …, 2021 - academic.oup.com
… a Mean (s.d.) DAS values are based on the non-imputed data. b P-value of χ 2 test for … a
Mean (s.d.) DAS values are based on the non-imputed data. b P-value of χ 2 test for difference …

Impact of obesity and overweight on C‐reactive protein concentrations and disease activity in rheumatoid arthritis: A systematic review and meta‐analysis

…, JA Esquivel‐Valerio, D VegaMorales… - International Journal …, 2023 - Wiley Online Library
Aim This study aims to assess the association of obesity and CRP concentrations in adult
patients with rheumatoid arthritis (RA), and its influence on measures of disease activity. …

Evaluation of the joint distribution at disease presentation of patients with rheumatoid arthritis: a large study across continents

SA Bergstra, A Chopra, M Saluja, D Vega-Morales… - RMD open, 2017 - rmdopen.bmj.com
Background Genetic and environmental risk factors for rheumatoid arthritis (RA) are population
dependent and may affect disease expression. Therefore, we studied tender and swollen …

Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients

…, AC Arana-Guajardo, D Vega-Morales… - Rheumatology …, 2015 - Springer
The incidence of tuberculosis (TB) in rheumatoid arthritis (RA) patients is up to four times
higher when compared to the general population, but their risk increases with the use of TNF-a …

Are the cut‐offs of the rheumatoid factor and anti‐cyclic citrullinated peptide antibody different to distinguish rheumatoid arthritis from their primary differential …

RA Pineda‐Sic, D VegaMorales… - International Journal …, 2024 - Wiley Online Library
Objective: Rheumatoid factor (RF) and anti‐cyclic citrullinated peptide antibody (anti‐CCP)
are commonly used for diagnosis of rheumatoid arthritis (RA), although other rheumatic …